COMMODORE CAPITAL LP - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 129 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
COMMODORE CAPITAL LP ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$6,581
-99.9%
1,935,6090.0%0.99%
-41.6%
Q3 2022$10,568,000
+21.1%
1,935,6090.0%1.70%
-8.0%
Q2 2022$8,730,000
-66.7%
1,935,609
-45.6%
1.85%
-68.5%
Q1 2022$26,245,0003,561,0525.86%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,773,474$2,376,4561.12%
AlphaCentric Advisors LLC 1,125,000$1,507,5000.86%
Tejara Capital Ltd 1,077,388$1,443,7000.82%
Palo Alto Investors LP 5,675,876$7,605,6740.72%
Birchview Capital, LP 571,832$766,2550.65%
Altium Capital Management LP 740,000$991,6000.52%
Avidity Partners Management LP 8,298,570$11,120,0840.45%
Worth Venture Partners, LLC 445,981$597,6150.36%
SILVERARC CAPITAL MANAGEMENT, LLC 561,955$753,0200.23%
DAFNA Capital Management LLC 192,678$258,1890.08%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders